BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30864163)

  • 21. Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D.
    Zhang C; Zhang J; Niu J; Zhou Z; Zhang J; Tian Z
    Hum Immunol; 2008 Aug; 69(8):490-500. PubMed ID: 18619507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired natural killer cell lysis in breast cancer patients with high levels of psychological stress is associated with altered expression of killer immunoglobin-like receptors.
    Varker KA; Terrell CE; Welt M; Suleiman S; Thornton L; Andersen BL; Carson WE
    J Surg Res; 2007 May; 139(1):36-44. PubMed ID: 17292412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic.
    Ferlazzo G; Thomas D; Lin SL; Goodman K; Morandi B; Muller WA; Moretta A; Münz C
    J Immunol; 2004 Feb; 172(3):1455-62. PubMed ID: 14734722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NK cells in autoimmune disease.
    Johansson S; Hall H; Berg L; Höglund P
    Curr Top Microbiol Immunol; 2006; 298():259-77. PubMed ID: 16323418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human cancer cells with stem cell-like phenotype exhibit enhanced sensitivity to the cytotoxicity of IL-2 and IL-15 activated natural killer cells.
    Yin T; Wang G; He S; Liu Q; Sun J; Wang Y
    Cell Immunol; 2016 Feb; 300():41-5. PubMed ID: 26677760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals.
    Robertson MJ; Cameron C; Lazo S; Cochran KJ; Voss SD; Ritz J
    Nat Immun; 1996-1997; 15(5):213-26. PubMed ID: 9390270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor.
    Borrego F; Robertson MJ; Ritz J; Peña J; Solana R
    Immunology; 1999 May; 97(1):159-65. PubMed ID: 10447727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production by human squamous cell carcinoma of a factor inducing activation and proliferation of immune cells.
    Hirabayashi H; Yasumura S; Lin WC; Amoscato A; Johnson JT; Herberman RB; Whiteside TL
    Arch Otolaryngol Head Neck Surg; 1995 Mar; 121(3):285-92. PubMed ID: 7873144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of bacillus Calmette-Guerin mediated natural killer cell activation.
    Suttmann H; Jacobsen M; Reiss K; Jocham D; Böhle A; Brandau S
    J Urol; 2004 Oct; 172(4 Pt 1):1490-5. PubMed ID: 15371877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural killer cells in human autoimmune disorders.
    Fogel LA; Yokoyama WM; French AR
    Arthritis Res Ther; 2013 Jul; 15(4):216. PubMed ID: 23856014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MICA/IL-12: A novel bifunctional protein for killer cell activation.
    Tietje A; Yang X; Yu X; Wei Y
    Oncol Rep; 2017 Mar; 37(3):1889-1895. PubMed ID: 28098874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of human natural killer cell migration and proliferation by the exodus subfamily of CC chemokines.
    Robertson MJ; Williams BT; Christopherson K; Brahmi Z; Hromas R
    Cell Immunol; 2000 Jan; 199(1):8-14. PubMed ID: 10675270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel role for interleukin-18 in human natural killer cell death: high serum levels and low natural killer cell numbers in patients with systemic autoimmune diseases.
    Shibatomi K; Ida H; Yamasaki S; Nakashima T; Origuchi T; Kawakami A; Migita K; Kawabe Y; Tsujihata M; Anderson P; Eguchi K
    Arthritis Rheum; 2001 Apr; 44(4):884-92. PubMed ID: 11315928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulatory NK cells in autoimmune disease.
    Tian Z; Gershwin ME; Zhang C
    J Autoimmun; 2012 Sep; 39(3):206-15. PubMed ID: 22704425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological effects of IL-21 on different immune cells and its role in autoimmune diseases.
    Gharibi T; Majidi J; Kazemi T; Dehghanzadeh R; Motallebnezhad M; Babaloo Z
    Immunobiology; 2016 Feb; 221(2):357-67. PubMed ID: 26466984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of human natural killer cells by lipopolysaccharide and generation of interleukin-1 alpha, beta, tumour necrosis factor and interleukin-6. Effect of IL-1 receptor antagonist.
    Conti P; Dempsey RA; Reale M; Barbacane RC; Panara MR; Bongrazio M; Mier JW
    Immunology; 1991 Aug; 73(4):450-6. PubMed ID: 1833315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.
    Doubrovina ES; Doubrovin MM; Vider E; Sisson RB; O'Reilly RJ; Dupont B; Vyas YM
    J Immunol; 2003 Dec; 171(12):6891-9. PubMed ID: 14662896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity.
    Reiter Z
    Crit Rev Immunol; 1993; 13(1):1-34. PubMed ID: 8466640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined Stimulation with Interleukin-18 and Interleukin-12 Potently Induces Interleukin-8 Production by Natural Killer Cells.
    Poznanski SM; Lee AJ; Nham T; Lusty E; Larché MJ; Lee DA; Ashkar AA
    J Innate Immun; 2017; 9(5):511-525. PubMed ID: 28633138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of in vitro porcine natural killer cell activity by recombinant interleukin-1 alpha, interleukin-2 and interleukin-4.
    Knoblock KF; Canning PC
    Immunology; 1992 Jun; 76(2):299-304. PubMed ID: 1634252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.